Related Experiment Videos

[Level of knowledge among patients treated with oral anticoagulant]

Réka Várnai1, Mária Végh, László Pótó

  • 1Pécsi Tudományegyetem, Orvos- és Egészségtudományi Koordinációs Központ Családorvostani Intézet és III. Belgyógyászati Klinika, Klinikai Központ, Pécs Akác u. 1. 7632. rekavarnai@yahoo.com

Orvosi Hetilap
|October 18, 2008
PubMed

Insights

Patient knowledge about acenocoumarol treatment, including adverse effects and interactions, is often inadequate. Improving patient education through a multidisciplinary team approach is essential for safer anticoagulation management.

Area of Science:

  • Pharmacology
  • Patient Education
  • Internal Medicine

Context:

  • Acenocoumarol treatment is frequently linked to major bleeding events, necessitating comprehensive patient understanding.
  • Assessing patient knowledge is crucial for mitigating risks associated with acenocoumarol therapy.

Purpose:

  • To evaluate patient awareness of acenocoumarol's adverse effects, drug interactions, and nutritional considerations.
  • To identify knowledge gaps in patients undergoing acenocoumarol treatment.

Summary:

  • A study involving 157 patients revealed significant gaps in knowledge regarding acenocoumarol's side effects, dietary interactions (71.4% unaware), and medication interactions (e.g., aspirin 24.4%, analgesics 23.0%).
  • Patients informed by a full healthcare team (doctors, nurses, dietitians) demonstrated better awareness of adverse effects compared to those informed by single providers.
  • Knowledge about drug interactions, such as with aspirin, analgesics, and vitamin K, was notably low across the patient cohort.

Impact:

  • Enhancing patient knowledge on acenocoumarol treatment is vital for improving adherence and reducing bleeding complications.
  • The findings underscore the importance of a multidisciplinary approach, involving nurses and dietitians, to significantly improve patient education and anticoagulation safety.
Abstract

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...